Investing Profile

Heather Preston

Advisor
Senior Advisor, TPG
San Francisco, California
Photo of Heather Preston, Advisor

Signal uses Gmail to reveal intro paths. Email content is never read.

Sign in with Google →
McKinsey & Company Network
141 CONNECTIONS
University of Oxford Network
96 CONNECTIONS
New Enterprise Associates (NEA) Network
42 CONNECTIONS
Harvard University Network
13 CONNECTIONS
cb
Advisor
Pivotal BioVentures Managing Partner
5
CompanyStageDateRound SizeTotal Raised
Azura Ophthalmics
Series BOct 2017$16M
$36M
Co-investors: Chris Nave (Brandon Capital Partners)
Entasis Therapeutics
Series BSep 2017$32M
$32M
Co-investors: Heather Behanna (SR One), Tracy Saxton (Dolby Family Ventures)
Alder Biopharmaceuticals
Series DApr 2012$38M
Series CDec 2007$40M
$78M
Co-investors: Peter Bisgaard (Pivotal bioVenture Partners)
Otonomy
Series BAug 2010$39M
$170M
Co-investors: Peter Bisgaard (Pivotal bioVenture Partners), Brian Dovey (Domain Associates), Niall O’Donnell (RiverVest), John McKearn (RiverVest)
Managing Partner Pivotal BioVentures2018 - 2022
Partner and Managing Director TPG Biotech2005 - 2018
Entrepreneur In Residence New Enterprise Associates (NEA)2002 - 2003
Engagement Manager McKinsey & Company1997 - 2002
Gastroenterologist and Hepatologist University of California, San Francisco1996 - 1997
Internal Medicine Physician Massachusetts General Hospital1994 - 1996
Postdoctoral Research Fellow Harvard University1991 - 1994
University of Oxford MD Medicine
St Bartholomews Hospital Medical School, University of London B.Sc. Hons Biochemistry